Large platform vs smaller platform
Novi vs Maximus: Track Record and Scale Compared (2026)
Novi $133/mo vs Maximus $133/mo. 2026 comparison of pricing, medication and support, with 12-month totals rather than first-month offers.
Published · Pricing as published in our provider dataset, synced · Editorial scores 7.0 and 7.0 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
Anyone shortlisting Novi against Maximus is choosing between two direct-pay GLP-1 programs that solve the same problem in materially different ways.
Track record separates them more than price does. Novi has 50,124 reviews behind it; Maximus has 2,896, which means less public evidence either way.
Rather than restate two feature lists, this compares the two on cost over time, medication access, price stability and the support each one includes. Where a figure is not published, that is stated rather than estimated.
The short answer
- Easier to price in advance
- Novi — Semaglutide from $133/mo, tirzepatide from $166/mo. The other side quotes after intake, so a like-for-like total is not available before you apply.
- Most predictable bill
- Maximus — Flat rate at every dose, so titration does not change what you are charged.
- Tirzepatide access
- Novi — Tirzepatide at $166/mo; the other side publishes semaglutide only.
- Longest public track record
- Novi — 50,124 patient reviews against 2,896.
Novi vs Maximus at a glance
Two programs, side by side, on their own published terms — with the rows that differ doing the work.
| Novi | Maximus | |
|---|---|---|
| Advertised price | Semaglutide from $133/mo, tirzepatide from $166/mo | $132.99/mo |
| Rate after promotions | $133/mo | $133/mo |
| Pricing structure | Published rate per medication | Flat rate at every dose |
| Medication | Compounded semaglutide and compounded tirzepatide | Compounded semaglutide |
| Membership fee | None | None |
| Payment options | Card only, no financing published | Card only, no financing published |
| State coverage | Not published | Not published |
| How fast you start | Online intake | Telemedicine intake, no clinic visits |
| Patient reviews | 50,124 | 2,896 |
| eRxDoctor score | 7.0/10 | 7.0/10 |
The real cost: six months and twelve
A first-month price is a customer-acquisition number. What matters is the total at the point most people are still in treatment, so both programs are extended to six and twelve months below.
| Novi | Maximus | |
|---|---|---|
| First month | $133 | $133 |
| Months 2 onward | $133/mo | $133/mo |
| 6-month total | $798 | $798 |
| 12-month total | $1,596 | $1,596 |
| Best published plan | No multi-month discount published | No multi-month discount published |
A like-for-like annual total is not available for : . Treat any comparison that quotes one as an estimate someone else has made for you.
Track record, and what review volume is worth
Novi has 50,124 reviews on record against 2,896 for Maximus. Star ratings sit close together across this whole market, so the count is more informative than the score: it tells you how many times the operation has been tested.
Scale matters in this category for unglamorous reasons — pharmacy relationships that hold when demand spikes, support that answers on a Sunday, and a refund process that exists. Maximus may run all of that well; there is simply less public evidence either way, and there is the standing caveat that the smallest patient base here, with limited published detail on tirzepatide.
The counterweight is that smaller platforms often provide more direct clinician access, and Maximus leads with a low flat rate with a simple direct-pay structure and nothing bolted on.
A closer look at Novi
$200 OFF - GLP-1 for $133 Today In this pairing, its distinguishing feature is the narrowest gap here between semaglutide and tirzepatide pricing, at $133 and $166.
From signup to first shipment: online intake, then free 2-day shipping with every order. Billing follows a published rate per medication structure.
What continues after the first shipment: no long-term contract, cancel anytime. Formulary: compounded semaglutide and compounded tirzepatide.
Novi pros
- Both compounded semaglutide and tirzepatide available
- Free 2-day shipping included with every order
- Competitive pricing: semaglutide from $133/month and tirzepatide from $166/month
- Largest patient base on this list, 50,000+ patients, signaling operational maturity
Novi cons
- No published outcome or weight loss guarantee
- Compounded medication only, no branded Ozempic, Wegovy, or Zepbound
- Tirzepatide ($166) costs more than the semaglutide entry rate
The cost of choosing this over Maximus: the $133 rate depends on a $200-off promotion and there is no outcome guarantee.
How Maximus works
$132.99 per Month What it is really selling here is a low flat rate with a simple direct-pay structure and nothing bolted on.
Practically: telemedicine intake, no clinic visits, home delivery, and a pricing model that is flat rate at every dose.
On the clinical side, prescriptions approved by licensed doctors, filled through U.S. pharmacies, prescribing compounded semaglutide.
Maximus pros
- Prescriptions approved by licensed doctors
- Medication filled through trusted U.S. pharmacies
- Low flat rate at $132.99/month
- Convenient telemedicine access with no clinic visits
Maximus cons
- No published outcome or weight loss guarantee
- Limited published detail on tirzepatide availability and program features
- Compounded medication only, no branded Ozempic, Wegovy, or Zepbound
The reservation worth holding, particularly next to Novi: the smallest patient base here, with limited published detail on tirzepatide.
Which one fits which patient
Choose Novi if:
- the level of clinical contact suits you: no long-term contract, cancel anytime
- you would get real value from the narrowest gap here between semaglutide and tirzepatide pricing, at $133 and $166
- you would rather use the platform with the longer public record (50,124 reviews)
- you want tirzepatide available without changing provider later
Choose Maximus if:
- what it leads on is worth paying for in your case: a low flat rate with a simple direct-pay structure and nothing bolted on
- you want the price you sign up at to survive titration
- you want to start on their timeline: telemedicine intake, no clinic visits
- the level of clinical contact suits you: prescriptions approved by licensed doctors, filled through U.S. pharmacies
Where each program concedes something
On price. Only Novi publishes a rate you can plan against (Semaglutide from $133/mo, tirzepatide from $166/mo). The other quotes after intake, which is a cost of a different kind: you cannot budget the year in advance.
On commitment. Neither publishes a multi-month discount, so both are month-to-month decisions and neither asks you to prepay for a response you have not had yet. Neither publishes financing options, so plan for the full amount each month.
On medication. Novi covers compounded semaglutide and compounded tirzepatide; Maximus covers compounded semaglutide. Only Novi publishes a tirzepatide route, which matters if semaglutide underdelivers.
On clinical contact. No long-term contract, cancel anytime at Novi; prescriptions approved by licensed doctors, filled through U.S. pharmacies at Maximus. Neither is a substitute for in-person care if you have complicating conditions, and both bill you directly rather than your insurer.
What the trials and the FDA say
Both platforms sell access to the same drug class, so the clinical record below applies equally to each.
The STEP 1 extension found participants regained roughly two-thirds of the weight they had lost within a year of stopping semaglutide, per Diabetes, Obesity and Metabolism.
SURMOUNT-1 put tirzepatide at roughly a 21% mean body-weight reduction at its highest dose over 72 weeks, per NEJM, SURMOUNT-1.
Which is to say: the medication decision belongs with a clinician, and the platform decision belongs with a spreadsheet.
Novi vs Maximus: common questions
Which is cheaper to start, Novi or Maximus?
Novi, at $133 against $133. Note that the cheapest first month and the cheapest year are often different providers here — check the 12-month row of the cost table before deciding on the entry price.
Which has more patient reviews, Novi or Maximus?
Novi, with 50,124 against 2,896. Ratings across this market cluster tightly, so volume is the more useful signal: it indicates how much operational load the platform has already absorbed, not how good the medication is.
Do Novi or Maximus take insurance?
Both run on a direct-pay basis: you pay the platform and it does not bill your insurer. Neither publishes HSA/FSA acceptance, so budget the full amount as out-of-pocket spending.
How fast can I start with Novi compared with Maximus?
Novi advertises online intake, with free 2-day shipping with every order. Maximus advertises telemedicine intake, no clinic visits, with home delivery. Both are subject to clinician review and to whether your state and health history clear, so treat the advertised timeline as a best case rather than a commitment.
Are Novi and Maximus legitimate?
Both are licensed telehealth platforms that route a prescription through a clinician review before anything is dispensed; neither sells medication without one. Novi operates on published rate per medication with pricing published upfront, Maximus on flat rate at every dose, published upfront. The meaningful due diligence is on the medication category and the terms, not on whether the platforms are real.
The verdict
Neither of these two publishes enough for a clean cost verdict, which is itself the finding. Novi leads on the narrowest gap here between semaglutide and tirzepatide pricing, at $133 and $166; Maximus leads on a low flat rate with a simple direct-pay structure and nothing bolted on.
Before choosing either, get the maintenance-dose price in writing. Without it, any comparison — including this one — is working with half the information.
Whichever you choose, diarise the month the introductory pricing ends and re-run the comparison then. Neither platform will remind you.
Keep comparing
- Gala vs NoviBudget vs premium
- Measured vs NoviCoaching-supported vs medication-only
- Sprout Health vs MaximusBudget vs premium
- Start Willow vs MaximusBudget vs premium
- Gala vs TMatesLarge platform vs smaller platform
- Refills vs NoviLarge platform vs smaller platform
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by Novi or Maximus, and does not sell treatment. Read our ranking methodology.